US Patent 11938101 Polymorphic forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide
Patent 11938101 was granted and assigned to PTC Therapeutics, Inc. on March, 2024 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 10, 2022
0
Date of Patent
March 26, 2024
0
Patent Applicant
Patent Application Number
17692133
0
Patent Citations
•••
Patent Inventor Names
Peter Giannousis
0
Mahmoud Mirmehrabi
0
Shazad Suchit
0
Christopher R. Cornell
0
Kieron E. Wesson
0
Paul Mollard
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11938101 Polymorphic forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
